The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study

[1]  Julia Salleron,et al.  Natural history of pediatric Crohn's disease: a population-based cohort study. , 2008, Gastroenterology.

[2]  David C Wilson,et al.  Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. , 2008, Gastroenterology.

[3]  J. Jahnsen,et al.  C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study , 2008, Gut.

[4]  A. Forbes,et al.  European evidence-based Consensus on the management of ulcerative colitis: Special situations. , 2008, Journal of Crohn's & colitis.

[5]  D. Griffiths,et al.  Outcome of childhood ulcerative colitis at 2 years , 2007, Acta paediatrica.

[6]  W. Sandborn,et al.  Inflammatory bowel disease: clinical aspects and established and evolving therapies , 2007, The Lancet.

[7]  M. Vatn,et al.  Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. , 2007, Gastroenterology.

[8]  A. Griffiths,et al.  The natural history of corticosteroid therapy for ulcerative colitis in children. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  M. Vatn,et al.  Ulcerative colitis and clinical course: Results of a 5‐year population‐based follow‐up study (the IBSEN study) , 2006, Inflammatory bowel diseases.

[10]  P. Munkholm,et al.  Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database , 2006, The American Journal of Gastroenterology.

[11]  J. Sýkora,et al.  Incidence of Crohn Disease in the Czech Republic in the Years 1990 to 2001 and Assessment of Pediatric Population with Inflammatory Bowel Disease , 2006, Journal of pediatric gastroenterology and nutrition.

[12]  P. Rutgeerts,et al.  Toll‐like receptor‐1, ‐2, and ‐6 polymorphisms influence disease extension in inflammatory bowel diseases , 2006, Inflammatory bowel diseases.

[13]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[14]  S. Auvin,et al.  Incidence, Clinical Presentation and Location at Diagnosis of Pediatric Inflammatory Bowel Disease: A Prospective Population-Based Study in Northern France (1988-1999) , 2005, Journal of pediatric gastroenterology and nutrition.

[15]  R. Farmer,et al.  Clinical patterns, natural history, and progression of ulcerative colitis , 1993, Digestive Diseases and Sciences.

[16]  H. Drummond,et al.  Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. , 2004, Gastroenterology.

[17]  J. Satsangi,et al.  IBD: a family affair. , 2004, Best practice & research. Clinical gastroenterology.

[18]  É. Lerebours,et al.  Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988–1999) , 2004, Gut.

[19]  T. Ahmad,et al.  Clinical relevance of advances in genetics and pharmacogenetics of IBD. , 2004, Gastroenterology.

[20]  M. Casparie,et al.  The Incidence of Pediatric Inflammatory Bowel Disease in the Netherlands: 1999–2001 , 2004, Journal of pediatric gastroenterology and nutrition.

[21]  P. Lakatos,et al.  Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. , 2003, World journal of gastroenterology.

[22]  R. Hoffmann,et al.  Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. , 2003, The Journal of pediatrics.

[23]  S. Murch,et al.  High‐dose azathioprine in children with inflammatory bowel disease , 2003, Alimentary pharmacology & therapeutics.

[24]  D. Jewell,et al.  Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. , 2002, Gastroenterology.

[25]  A. Zinsmeister,et al.  The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. , 2001, Gastroenterology.

[26]  R. Lynn,et al.  Prospective survey of childhood inflammatory bowel disease in the British Isles , 2001, The Lancet.

[27]  N. Camp,et al.  Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians , 2001, Gut.

[28]  S. Vermeire,et al.  Inflammatory bowel disease in spouses and their offspring. , 2001, Gastroenterology.

[29]  S. Hanauer,et al.  Advanced Therapy of Inflammatory Bowel Disease , 2000 .

[30]  D. Heresbach,et al.  Incidence des maladies inflammatoires du tube digestif chez l'enfant en Bretagne (1994–1997) , 2000 .

[31]  H. Jenkins,et al.  The incidence of childhood inflammatory bowel disease in Wales , 2000, European Journal of Pediatrics.

[32]  E. Lindberg,et al.  Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. , 2000, Journal of pediatric gastroenterology and nutrition.

[33]  D. Heresbach,et al.  [Incidence of inflammatory bowel disease in children in Brittany (1994-1997). Breton association of study and research on digestive system diseases (Abermad)]. , 2000, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[34]  R. Baldassano,et al.  Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. , 1999, Journal of pediatric gastroenterology and nutrition.

[35]  J. Satsangi,et al.  Genetic markers may predict disease behavior in patients with ulcerative colitis. , 1997, Gastroenterology.

[36]  P. Munkholm,et al.  Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. , 1997, Scandinavian journal of gastroenterology.

[37]  J. Markowitz,et al.  Clinical outcome of ulcerative colitis in children. , 1996, The Journal of pediatrics.

[38]  D. Jewell,et al.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease , 1996, The Lancet.

[39]  H. Jenkins,et al.  The epidemiology of paediatric inflammatory bowel disease. , 1996, Archives of disease in childhood.

[40]  J. Colombel,et al.  Incidence of inflammatory bowel disease in northern France (1988-1990). , 1994, Gut.

[41]  S. Hanauer,et al.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy. , 1994, The New England journal of medicine.

[42]  A. Griffiths,et al.  Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial. , 1993, Journal of pediatric gastroenterology and nutrition.

[43]  J. Barton,et al.  Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease. , 1990, The Quarterly journal of medicine.

[44]  K. Haug,et al.  Chronic inflammatory bowel disease in children in western Norway. , 1989, Journal of pediatric gastroenterology and nutrition.

[45]  J. Barton,et al.  Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. , 1989, Gut.

[46]  G. Hellers,et al.  Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. , 1987, Scandinavian journal of gastroenterology.

[47]  R. Farmer,et al.  Long‐Term Prognosis of Ulcerative Colitis with Onset in Childhood or Adolescence , 1979, Journal of clinical gastroenterology.

[48]  D. Sachar,et al.  THE EXTRA-INTESTINAL COMPLICATIONS OF CROHN'S DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTS , 1976, Medicine.